Puppet Chemistry
Four clueless lab scientists fail to buy the new Agilent 1200 Infinity Series. See what happens when their boss finds out. Then create your own puppet drama.
Here’s something you don’t see every day: puppets in the lab. Check out this funny new video from Agilent Technologies and watch as four clueless lab scientists make one very big mistake—they tell their boss they didn’t buy the new Agilent 1200 Infinity Series he authorized. Let’s just say he isn’t very happy. Then after you watch the Agilent version you can create and share your own customized puppet movie that features you and your colleagues.
The Agilent 1200 Infinity Series offers a continuum of future-proof, compatible and upgradeable UHPLC solutions for any application or budget. It all started when Agilent launched the Agilent 1290 Infinity LC and ended the UHPLC debate. Now Agilent has raised the HPLC standard. The new 1220 and 1260 Infinity LC systems give you RRLC capabilities at an HPLC price: 600 bar and 80 Hz detector speed. All systems are up to 10x more sensitive and 100% compatible with all your HPLC methods to ensure riskless replacement of existing instruments. Best of all, it’s from a name you trust for the highest quality—Agilent Technologies.
Watch the movie then create your own right here: www.puppetchemistry.com.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
